Armis Biopharma, Inc.
Armis Biopharma is focused on next-generation antimicrobial platforms targeting wound healing, disinfecting, and decontamination. Their patented Veriox® technology platform offers a single-stop antimicrobial/antitoxin solution aimed at combating antimicrobial resistance (AMR) pathogens and chemical/biological warfare agents. The company's mission is to develop novel, targeted antimicrobial therapies to reduce infections and human suffering.
Industries
Nr. of Employees
small (1-50)
Armis Biopharma, Inc.
2401 Research Blvd., Ste. 205, Fort Collins, CO 80562
Patents
Compositions and methods for remediating chemical warfare agent exposed skin
US-11969399-B2
View DetailsAntimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same
US-11839213-B2
View DetailsCompositions comprising peroxyacid and methods for producing and using the same
US-11284621-B2
View DetailsOxidative compositions and methods for stimulating the growth of osteoblasts and use in dental coatings and jaw bone augmentation
US-11246807-B2
View DetailsAntimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same
US-11006629-B2
View Details
Compositions and methods for remediating chemical warfare agent exposed skin
US-11969399-B2
View DetailsAntimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same
US-11839213-B2
View DetailsCompositions comprising peroxyacid and methods for producing and using the same
US-11284621-B2
View DetailsOxidative compositions and methods for stimulating the growth of osteoblasts and use in dental coatings and jaw bone augmentation
US-11246807-B2
View DetailsAntimicrobial, disinfecting, and wound healing compositions and methods for producing and using the same
US-11006629-B2
View DetailsProducts
VeriCyn wound wash
FDA-cleared wound wash formulated for postsurgical wound care, wound lavage, and surgical wound washouts; reported to remove bioburden and to stimulate healing processes.
ArmiClenz disinfectant
EPA-registered clinical-grade surface disinfectant formulated to kill bacteria and viruses on surfaces while being described as non-toxic and safe for many surfaces.
ArmiGard oral appliance solution
Solution formulated for disinfection and pathogen removal from oral appliances such as retainers, aligners, mouthguards and CPAP masks.
ArmiVet veterinary surgical and wound wash
Topical surgical and wound wash formulated for use in veterinary hospitals, clinics, and animal-care settings to clean and debride wounds.
ArmiCare hand sanitizer
Alcohol-based hand sanitizer formulated with 75% ethyl alcohol plus hydrogen peroxide and glycerin to provide antiseptic activity while conditioning skin.
Veriox DECON (pipeline)
Decontamination product in development intended to neutralize chemical and biological agents for military and civilian use; reported to have activity against spores and to attract government interest and funding.
VeriCyn wound wash
FDA-cleared wound wash formulated for postsurgical wound care, wound lavage, and surgical wound washouts; reported to remove bioburden and to stimulate healing processes.
ArmiClenz disinfectant
EPA-registered clinical-grade surface disinfectant formulated to kill bacteria and viruses on surfaces while being described as non-toxic and safe for many surfaces.
ArmiGard oral appliance solution
Solution formulated for disinfection and pathogen removal from oral appliances such as retainers, aligners, mouthguards and CPAP masks.
ArmiVet veterinary surgical and wound wash
Topical surgical and wound wash formulated for use in veterinary hospitals, clinics, and animal-care settings to clean and debride wounds.
ArmiCare hand sanitizer
Alcohol-based hand sanitizer formulated with 75% ethyl alcohol plus hydrogen peroxide and glycerin to provide antiseptic activity while conditioning skin.
Veriox DECON (pipeline)
Decontamination product in development intended to neutralize chemical and biological agents for military and civilian use; reported to have activity against spores and to attract government interest and funding.
Services
Execution of product development programs supported by non-dilutive government grants and defense contracts to develop decontamination and antimicrobial products for civilian and military use.
Execution of product development programs supported by non-dilutive government grants and defense contracts to develop decontamination and antimicrobial products for civilian and military use.
Expertise Areas
- Antimicrobial product development
- Wound care and wound irrigation
- Surface disinfection and environmental decontamination
- Decontamination for chemical/biological threats (CBRN decon)
Key Technologies
- Peracid/hydrogen peroxide oxidative antimicrobial chemistry
- Non-systemic topical antimicrobial formulations
- Wound irrigation/wash formulation
- Surface disinfectant chemistries
News & Updates
Armis Biopharma announced the appointment of Michael J. Voss as CEO, replacing Ted Ziemann.
The company announced FDA clearance for VeriCyn® Wound Wash.
Donation of disinfectant to hurricane victims.
The company received a contract to develop Veriox® DECON for battlefield wounds.
Research shows Veriox® DECON can kill anthrax.
FDA clearance for VeriFixx™ Small Bone Implant.
Armis Biopharma announced the appointment of Michael J. Voss as CEO, replacing Ted Ziemann.
The company announced FDA clearance for VeriCyn® Wound Wash.
Donation of disinfectant to hurricane victims.
The company received a contract to develop Veriox® DECON for battlefield wounds.
Research shows Veriox® DECON can kill anthrax.
FDA clearance for VeriFixx™ Small Bone Implant.